UnknownNot Applicable

Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns

France3,060 participantsStarted 2020-05-11

Plain-language summary

The purpose of this study is to characterize the incidence and clinical features of the maternal COVID 19 infection, as well as the associated morbidity of the mother and the child, in the French context

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Any woman with : either proven COVID-19 infection= positive PCR test, OR probable COVID-19 infection = typical clinical symptoms AND typical pulmonary radiology * during pregnancy or within 42 days postpartum, * whether or not this diagnosis is followed by hospitalization, Exclusion Criteria: * Refusal to participate * Major protected (curator, trusteeship)

What they're measuring

Joint evaluation of morbi-mortality for mother and child up to 12 weeks postpartum

Timeframe: At12 weeks after delivery

Trial details

NCT IDNCT04463758

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-02

Contact for this trial

Catherine Deneux-Tharaux, MD, PhD

+33 1 42 34 55 79 catherine.deneux-tharaux@inserm.fr

View on ClinicalTrials.gov More covid19 Infection trials